HOME >> BIOLOGY >> NEWS
Cost-effectiveness study of three antimalarial drug combinations in Tanzania

Researchers from the London School of Hygiene and Tropical Medicine have evaluated the cost-effectiveness of the three alternative combinations of drugs now recommended for the treatment of malaria in East Africa. They found that the drug combination that was the most expensive in the short term was in fact the most cost-effective, because its superior performance in curing malaria reduced the need for further treatment.

Resistance to malaria drugs is extremely common. The World Health Organization and other authorities now recommend the use of one of the new type of treatments (based on the Chinese drug artemisinin) combined with one of the older malaria drugs. It is thought that this combination approach will delay the appearance of artemisinin resistance. The combination of artemether and lumefantrine out-performed the other drug combinations in this research, which was conducted in Tanzania. The researchers say artemether and lumefantrine should be the preferred option in this part of Africa.


'"/>

Contact: Andrew Hyde
press@plos.org
44-122-346-3330
Public Library of Science
9-Oct-2006


Page: 1

Related biology news :

1. Cost-effectiveness of treating multidrug-resistant tuberculosis
2. New study warns limited carbon market puts 20 percent of tropical forest at risk
3. Clones on task serve greater good, evolutionary study shows
4. Pollution causes 40 percent of deaths worldwide, study finds
5. A study by the MUHC and McGill University opens a new door to understanding cancer
6. New study suggests Concord grape juice may provide protection against breast cancer
7. Preclinical study links gene to brain aneurysm formation
8. In limiting life span, study finds booming bacteria innocent
9. Multicenter study nets new lung tumor-suppressor gene
10. MIT study: Maturity brings richer memories
11. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2019)... ... July 25, 2019 , ... ... the first mixed reality headsets to include a new generation eye tracker with ... in Los Angeles, California (July 30 - August 1). SIGGRAPH attendees will ...
(Date:7/23/2019)... Conn. (PRWEB) , ... July 23, 2019 , ... ... that provides personalized, easy-to-understand, web-based genetic counseling, today announced that the company has ... related to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease. , The ...
(Date:7/23/2019)... ... July 23, 2019 , ... NanoFUSE is pleased ... strip indicated for spine and orthopedic use. Bioactive glass is a calcium phosphate ... been clinically-proven in orthopedics for over 30 years and now NanoFUSE Biologics has ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 06, 2019 , ... The ... the launch of a community project that will engage middle and early high ... project, entitled “A Youth-Led Citizen Science Network for Community Environmental Assessment.” Collaborative partners ...
(Date:7/19/2019)... (PRWEB) , ... July 18, 2019 , ... ... Instrumente) announced their investment to enlarge their current piezo motion facilities in Lederhose, ... offer 3 floors for multilayer piezo ceramic assembly production in addition to general ...
(Date:7/11/2019)... VEGAS (PRWEB) , ... July 11, 2019 , ... At ... R3 provided complimentary regenerative therapies to eight military Veterans under the R3 Heroes Program. ... being complimentary. , The R3 Heroes Program allow anyone to nominate a military Veteran, ...
(Date:6/18/2019)... N.J. (PRWEB) , ... June 17, 2019 , ... ... announced that they have entered into an agreement for production and manufacturing of ... for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for ...
Breaking Biology Technology:
Cached News: